Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rab33A: characterization, expression, and suppression by epigenetic modification.

Elaine Cheng1, Sergio E Trombetta, Daniela Kovacs

  • 1Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520-8059, USA.

The Journal of Investigative Dermatology
|July 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of [<sup>111</sup>In]In-CHX-A″-DTPA-αCD68 for ImmunoSPECT to Image Murine Macrophages.

Molecular pharmaceutics·2026
Same author

Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

Journal for immunotherapy of cancer·2026
Same author

Advances in Cancer Immunotherapy for Solid Tumors.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Ex Vivo Expansion of Melanoma Tumor-Infiltrating Lymphocytes Leads to a Dominant Exhausted T-cell Population with a Lack of Memory Markers.

Cancer immunology research·2026
Same author

Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors.

International journal of molecular sciences·2026
Same author

Lipidomics in Melanoma: Insights into Disease Progression and Therapeutical Targets.

International journal of molecular sciences·2026
Same journal

An Integrated Skin Cell Atlas Decodes the Pilosebaceous Unit.

The Journal of investigative dermatology·2026
Same journal

Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

The Journal of investigative dermatology·2026
Same journal

Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.

The Journal of investigative dermatology·2026
Same journal

Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

The Journal of investigative dermatology·2026
Same journal

Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.

The Journal of investigative dermatology·2026
Same journal

The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

The Journal of investigative dermatology·2026
See all related articles

Rab33A, an X-linked gene, is downregulated in melanoma and its suppression is linked to DNA methylation. This finding is crucial for understanding X-chromosome gene disorders and carcinogenesis.

Area of Science:

  • Genetics
  • Cell Biology
  • Oncology

Background:

  • Rab33A is a small GTPase, X-linked gene expressed in brain, lymphocytes, and melanocytes.
  • Rab33A is downregulated in melanoma cells.
  • Aberrant Rab33A downregulation occurs early in melanocytic lesions, including giant congenital nevi.

Purpose of the Study:

  • To investigate the role of Rab33A in normal melanocytes and melanoma.
  • To understand the regulatory mechanisms of Rab33A expression.
  • To explore the implications of Rab33A dysregulation in carcinogenesis and X-linked disorders.

Main Methods:

  • Colocalization studies of Rab33A with melanosomal proteins in normal melanocytes.
  • Functional assays using constitutively active GTPase mutants.

Related Experiment Videos

  • Analysis of Rab33A expression in melanocytic lesions.
  • Bisulfite DNA methylation analysis of the Rab33A promoter region.

    • Main Results:

    • Rab33A colocalizes with melanosomal proteins; a mutant suppresses melanosome transport.
    • Downregulation of Rab33A is an early event in melanocytic lesions.
    • Rab33A expression is regulated by DNA methylation of its promoter.
    • Suppression in melanoma mimics X-linked gene silencing, not tissue-specific regulation.

    Conclusions:

    • Rab33A plays a role in melanosome transport in normal melanocytes.
    • Rab33A downregulation is an early event in melanoma development, regulated by DNA methylation.
    • Dysregulation of Rab33A may contribute to carcinogenesis and disorders involving X-linked genes and vesicular transport.